Skip to content

Effect of pentoxifylline in treatment of patients with slow flow coronary arteries

Evaluation of the effect of oral pentoxifylline on reducing chest pain in ischemic patients with slow flow coronary arteries

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT20210711051842N1
Enrollment
40
Registered
2022-04-30
Start date
2022-04-09
Completion date
Unknown
Last updated
2022-05-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pentoxifylline in patients with slow flow coronary arteries.

Interventions

Intervention group: patients with slow flow coronary arteries in angiography will be treated with standard medicine for two weeks and in case of pain continuation, will be treated with oral pentoxifyl

Sponsors

Mashhad University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients with slow flow coronary arteries in angiography

Exclusion criteria

Exclusion criteria: Age more than thirty years Creatinine clearance less than 30 Severe aortic stenosis Severe mitral stenosis

Design outcomes

Primary

MeasureTime frame
Severity of chest pain through Likert scale. Timepoint: Evaluation of chest pain after angiography and after two weeks and one month. Method of measurement: Questionnarie for evaluating severity,frequency and duration of chest pain.

Secondary

MeasureTime frame
Frequency chest pain. Timepoint: at the time of angiography and two weeks and one month later. Method of measurement: Questionnaire usage.;Duration of chest pain. Timepoint: at the time of angiography and two weeks and one month later. Method of measurement: Questionnaire usage.;Severity of chest pain based on Canadian cardiovascular society score (CCS). Timepoint: at the time of angiography and two weeks and one month later. Method of measurement: Questionnaire usage.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactReza Teimouri Dastjerdan

Mashhad University of Medical Sciences

teimouridr971@mums.ac.ir+98 51 3867 9747

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026